Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Summit Therapeutics Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$smmt.png) Summit Therapeutics Inc. Common Stock (SMMT)

Summit Therapeutics shares are up amid reports of a potential $15B licensing deal with AstraZeneca. Ivonescimab data disappoints in Western patients, causing concern.

### About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc. Common Stock (SMMT) is a biopharmaceutical company.  
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the [Stocks](/list/stocks) and  category.

### Insights [#](/topic/$smmt/insights)
- Summit Therapeutics Inc. Common Stock (SMMT) market dominance near a 52-week low at XXXXX.
- Summit Therapeutics Inc. Common Stock (SMMT) creators hit XXX which is XXX% higher than it's daily average.
- Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) galaxy scoreβ„’ is up XXXXXX% from the previous month.
- Summit Therapeutics Inc. Common Stock (SMMT) engagements is up XXXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXXXXXX% from the previous week.

### Price: $XXXXX [#](/topic/$smmt/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/close.tsv)  
The XXXX% price increase appears to be driven by positive market sentiment, hype from top creators, the anticipation of Phase X data, and a potential deal with AstraZeneca, fueled by rumors of a $XX billion partnership and increased social engagement.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | XXXX%  |

**1-Year High**: $XXXXX on 2025-04-24  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/$smmt/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/alt_rank.tsv)  
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #196 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXX -XXX  
**6 Months**: XXX +155  
**1 Year**: XXX -XX  
**1-Year High**: XXXXX on 2025-08-11  
**1-Year Low**: X on 2025-02-09  
  
  
### Galaxy Score: XXXXX [#](/topic/$smmt/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +28  
**1 Month**: XX +31  
**6 Months**: XX -XX  
**1 Year**: XX +4  
**1-Year High**: XX on 2025-04-22  
**1-Year Low**: X on 2025-03-18  
  
  
### Engagements: XXXXXXX [#](/topic/$smmt/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/interactions.tsv)  
**Current Value**: XXXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX +247%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +18%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-04-25  
**1-Year Low**: XXX on 2025-09-20  

| Social Network | X       | Reddit | YouTube |
| -------------- | -       | ------ | ------- |
| Engagements    | XXXXXXX | XX     | X       |
  

  
  
### Mentions: XXX [#](/topic/$smmt/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX -XXXX%  
**1 Year**: XXXXXX +61%  
**1-Year High**: XXX on 2025-07-18  
**1-Year Low**: XX on 2025-10-07  

| Social Network | X   | Reddit | YouTube |
| -------------- | -   | ------ | ------- |
| Mentions       | XXX | X      | X       |
  

  
  
### Creators: XXX [#](/topic/$smmt/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XXX% from XX in the previous XX hours
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +34%  
**1 Year**: XXXXX +105%  
**1-Year High**: XXX on 2025-07-18  
**1-Year Low**: XX on 2025-10-07  

The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | X    | XXXXXX    | X     | XXXXXX      |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XXXXXX      |
| [@Banana_Oncology](/creator/twitter/Banana_Oncology) | X    | XXXXX     | X     | XXXXXX      |
| [@doepke_michel](/creator/twitter/doepke_michel)     | X    | XXXXX     | X     | XXXXX       |
| [@JacobPlieth](/creator/twitter/JacobPlieth)         | X    | XXXXXX    | X     | XXXXX       |
| [@earnings_guy](/creator/twitter/earnings_guy)       | X    | XXXXXX    | X     | XXXXX       |
| [@planert41](/creator/twitter/planert41)             | X    | XXXXXX    | X     | XXXXX       |
| [@trentkelp](/creator/twitter/trentkelp)             | X    | XXXXX     | X     | XXXXX       |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | X    | XXXXX     | X     | XXXXX       |
| [@SamFazeli8](/creator/twitter/SamFazeli8)           | XX   | XXXXX     | X     | XXXXX       |

[View More](/list/creators/$smmt/100)
  
  
### Sentiment: XX% [#](/topic/$smmt/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +16%  
**6 Months**: XX% +5%  
**1 Year**: XX% +14%  
**1-Year High**: XXX% on 2025-10-06  
**1-Year Low**: XX% on 2025-03-23  

**Most Supportive Themes**
- **Upcoming Phase X Data:** (40%) The anticipation of upcoming Phase X data fuels investor excitement.
- **Bullish Sentiment and Recognition:** (30%) Positive mentions and recognition of Summit Therapeutics as a potential long-term holding boost investor confidence.
- **Strategic Partnerships:** (10%) Strategic collaborations, such as the ADC combo deal with Pfizer, are viewed positively by investors.
  
**Most Critical Themes**
- **Competition Intensification:** (3%)  Investors are concerned about increased competition in the PD-1/VEGF bispecific antibody market.
- **Conflicting Macroeconomic Signals:** (2%)  Uncertainty is introduced by conflicting macroeconomic signals.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |
| Reddit  | XX       | X%  | XX      | X%  | X        | X%  |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$smmt/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.075%  
**1 Month**: XXXXX% +0.054%  
**6 Months**: XXXXX% -XXXX%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2025-04-25  
**1-Year Low**: XXXXXX% on 2025-10-07  
  
  
### Market Dominance: XXXXX% [#](/topic/$smmt/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2025-09-10  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$smmt/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$smmt/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX -$13%  
**1 Month**: $XXXXXXXXXXXXXX +$0.05%  
**6 Months**: $XXXXXXXXXXXXXX -$43%  
**1 Year**: $XXXXXXXXXXXXXX -$9.90%  
**1-Year High**: $XXXXXXXXXXXXXX on 2025-04-24  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours

[Apple, Inc. (AAPL)](/topic/$aapl)
[Netflix Inc (NFLX)](/topic/$nflx)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Uber Technologies, Inc. (UBER)](/topic/$uber)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Lyft, Inc. Class A Common Stock (LYFT)](/topic/$lyft)
[Nike Inc (NKE)](/topic/$nke)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[NVIDIA Corp. (NVDA)](/topic/$nvda)

**Top topics mentioned**
In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours

[$dcth](/topic/$dcth), [stocks technology](/topic/stocks-technology), [stocks healthcare](/topic/stocks-healthcare), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks communication services](/topic/stocks-communication-services), [stocks financial services](/topic/stocks-financial-services), [$aapl](/topic/$aapl), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$nflx](/topic/$nflx), [$9926hk](/topic/$9926hk), [stocks basic materials](/topic/stocks-basic-materials), [stocks industrials](/topic/stocks-industrials), [johnson johnson](/topic/johnson-johnson), [$uber](/topic/$uber), [$mrk](/topic/$mrk), [$lyft](/topic/$lyft), [stocks](/topic/stocks), [$nke](/topic/$nke), [china](/topic/china), [coins made in usa](/topic/coins-made-in-usa), [$gsun](/topic/$gsun), [$pfe](/topic/$pfe), [$nvda](/topic/$nvda), [ibm](/topic/ibm), [tesla](/topic/tesla), [$clf](/topic/$clf), [$azn](/topic/$azn), [$qcom](/topic/$qcom), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$bntx](/topic/$bntx), [$dx](/topic/$dx), [$dave](/topic/$dave), [stocks banks](/topic/stocks-banks), [$pep](/topic/$pep), [$mrna](/topic/$mrna), [$sbux](/topic/$sbux), [advanced micro devices](/topic/advanced-micro-devices), [$intc](/topic/$intc), [discord](/topic/discord), [$cat](/topic/$cat), [$wmt](/topic/$wmt), [$ma](/topic/$ma), [stocks energy](/topic/stocks-energy), [exxon mobil](/topic/exxon-mobil), [$mtc](/topic/$mtc), [$hd](/topic/$hd), [$ba](/topic/$ba), [$jnj](/topic/$jnj), [$tgt](/topic/$tgt), [about to](/topic/about-to), [$akesf](/topic/$akesf), [eli lilly](/topic/eli-lilly), [$hbt](/topic/$hbt), [walt disney](/topic/walt-disney), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$wfc](/topic/$wfc), [$gm](/topic/$gm), [warner bros discovery inc](/topic/warner-bros-discovery-inc), [costco](/topic/costco), [procter gamble](/topic/procter-gamble), [goldman sachs](/topic/goldman-sachs), [$amzn](/topic/$amzn), [$pypl](/topic/$pypl), [block inc](/topic/block-inc), [microsoft](/topic/microsoft), [iii](/topic/iii), [momentum](/topic/momentum), [$exel](/topic/$exel), [$lly](/topic/$lly), [$insm](/topic/$insm), [click the](/topic/click-the), [investment](/topic/investment), [$onc](/topic/$onc), [$bmy](/topic/$bmy), [$orcl](/topic/$orcl), [$bac](/topic/$bac), [$ibm](/topic/$ibm), [$gs](/topic/$gs), [$amd](/topic/$amd), [$sq](/topic/$sq), [morgan stanley](/topic/morgan-stanley), [manat](/topic/manat), [$cmnd](/topic/$cmnd), [coins defi](/topic/coins-defi), [$msft](/topic/$msft), [market cap](/topic/market-cap), [$til](/topic/$til), [$eose](/topic/$eose), [$ge](/topic/$ge), [miller](/topic/miller), [spikes](/topic/spikes), [$googl](/topic/$googl), [jpmorgan chase](/topic/jpmorgan-chase), [$cost](/topic/$cost), [protocol](/topic/protocol), [mcdonalds corp](/topic/mcdonalds-corp), [$xom](/topic/$xom), [jacob](/topic/jacob), [$mdgl](/topic/$mdgl), [united therapeutics corp](/topic/united-therapeutics-corp)

### Top Social Posts [#](/topic/$smmt/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$SMMT (-8.7% pre) Summit Therapeutics Shares Dip After Q3 Results Ivonescimab Strategy Moves Forward - msn"  
[X Link](https://x.com/OpenOutcrier/status/1980250481151606935) [@OpenOutcrier](/creator/x/OpenOutcrier) 2025-10-20T12:31Z 80.1K followers, 2121 engagements


"**Summit Therapeutics Inc.** ($SMMT): SMMT Announces Positive Phase III Data Plans FDA Approval Filing"  
[Reddit Link](https://redd.it/1obh6hf) [@Educational_Cup9809](/creator/reddit/Educational_Cup9809) 2025-10-20T12:18Z X followers, X engagements


"$SMMT plans to submit an application for approval of Ivonescimab to the FDA in Q4 - a very opportunistic approach in my opinion. Shares down X% pre-market. $MRK flat"  
[X Link](https://x.com/doepke_michel/status/1980235313235800146) [@doepke_michel](/creator/x/doepke_michel) 2025-10-20T11:31Z 5636 followers, 1357 engagements


"Summit Therapeutics $SMMT Q3-25. Results: πŸ“Š Adj. EPS: -$0.13 πŸ”΄ πŸ’° Revenue: $X πŸ”΄ πŸ“ˆ Net Loss: $231.8M πŸ”Ž Summit plans BLA submission for ivonescimab in Q4 2025 following strong Phase III HARMONi trial results"  
[X Link](https://x.com/Earnings_Time/status/1980233237701292045) [@Earnings_Time](/creator/x/Earnings_Time) 2025-10-20T11:22Z 12.3K followers, 1426 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Summit Therapeutics Inc. Common Stock Graphic Summit Therapeutics Inc. Common Stock (SMMT)

Summit Therapeutics shares are up amid reports of a potential $15B licensing deal with AstraZeneca. Ivonescimab data disappoints in Western patients, causing concern.

About Summit Therapeutics Inc. Common Stock

Summit Therapeutics Inc. Common Stock (SMMT) is a biopharmaceutical company.
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the Stocks and category.

Insights #

  • Summit Therapeutics Inc. Common Stock (SMMT) market dominance near a 52-week low at XXXXX.
  • Summit Therapeutics Inc. Common Stock (SMMT) creators hit XXX which is XXX% higher than it's daily average.
  • Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXX% from the previous week.
  • Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXXXXX% from the previous week.
  • Summit Therapeutics Inc. Common Stock (SMMT) galaxy scoreβ„’ is up XXXXXX% from the previous month.
  • Summit Therapeutics Inc. Common Stock (SMMT) engagements is up XXXXXX% from the previous week.
  • Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXXXXXX% from the previous week.

Price: $XXXXX #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The XXXX% price increase appears to be driven by positive market sentiment, hype from top creators, the anticipation of Phase X data, and a potential deal with AstraZeneca, fueled by rumors of a $XX billion partnership and increased social engagement.

24-Hour 7-Day 30-Day
-XXXX% -XXXX% XXXX%

1-Year High: $XXXXX on 2025-04-24
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXX #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #196 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX -XXX
6 Months: XXX +155
1 Year: XXX -XX
1-Year High: XXXXX on 2025-08-11
1-Year Low: X on 2025-02-09

Galaxy Score: XXXXX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +28
1 Month: XX +31
6 Months: XX -XX
1 Year: XX +4
1-Year High: XX on 2025-04-22
1-Year Low: X on 2025-03-18

Engagements: XXXXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +247%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +18%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-09-20

Social Network X Reddit YouTube
Engagements XXXXXXX XX X

Mentions: XXX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX -XXXX%
1 Year: XXXXXX +61%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-10-07

Social Network X Reddit YouTube
Mentions XXX X X

Creators: XXX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XXX% from XX in the previous XX hours Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX +34%
1 Year: XXXXX +105%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-10-07

The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@Biotech2k1 X XXXXXX X XXXXXX
@semodough X XXXXXX X XXXXXX
@Banana_Oncology X XXXXX X XXXXXX
@doepke_michel X XXXXX X XXXXX
@JacobPlieth X XXXXXX X XXXXX
@earnings_guy X XXXXXX X XXXXX
@planert41 X XXXXXX X XXXXX
@trentkelp X XXXXX X XXXXX
@MarcJacksonLA X XXXXX X XXXXX
@SamFazeli8 XX XXXXX X XXXXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +16%
6 Months: XX% +5%
1 Year: XX% +14%
1-Year High: XXX% on 2025-10-06
1-Year Low: XX% on 2025-03-23

Most Supportive Themes

  • Upcoming Phase X Data: (40%) The anticipation of upcoming Phase X data fuels investor excitement.
  • Bullish Sentiment and Recognition: (30%) Positive mentions and recognition of Summit Therapeutics as a potential long-term holding boost investor confidence.
  • Strategic Partnerships: (10%) Strategic collaborations, such as the ADC combo deal with Pfizer, are viewed positively by investors.

Most Critical Themes

  • Competition Intensification: (3%) Investors are concerned about increased competition in the PD-1/VEGF bispecific antibody market.
  • Conflicting Macroeconomic Signals: (2%) Uncertainty is introduced by conflicting macroeconomic signals.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXXX XX% XXXXXX XX% XXXXXX XX%
Reddit XX X% XX X% X X%
YouTube X X% X X% X X%
Total XXXXXX XX% XXXXXX XX% XXXXXX XX%

Social Dominance: XXXXX% #


Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.075%
1 Month: XXXXX% +0.054%
6 Months: XXXXX% -XXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-04-25
1-Year Low: XXXXXX% on 2025-10-07

Market Dominance: XXXXX% #


Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-09-10

Market Cap: $XXXXXXXXXXXXXX #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX -$13%
1 Month: $XXXXXXXXXXXXXX +$0.05%
6 Months: $XXXXXXXXXXXXXX -$43%
1 Year: $XXXXXXXXXXXXXX -$9.90%
1-Year High: $XXXXXXXXXXXXXX on 2025-04-24
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours

Apple, Inc. (AAPL) Netflix Inc (NFLX) Johnson & Johnson (JNJ) Uber Technologies, Inc. (UBER) Merck & Co., Inc. (MRK) Lyft, Inc. Class A Common Stock (LYFT) Nike Inc (NKE) Pfizer, Inc. (PFE) NVIDIA Corp. (NVDA)

Top topics mentioned In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours

$dcth, stocks technology, stocks healthcare, stocks consumer cyclical, stocks communication services, stocks financial services, $aapl, stocks consumer defensive, $nflx, $9926hk, stocks basic materials, stocks industrials, johnson johnson, $uber, $mrk, $lyft, stocks, $nke, china, coins made in usa, $gsun, $pfe, $nvda, ibm, tesla, $clf, $azn, $qcom, stocks bitcoin treasuries, $bntx, $dx, $dave, stocks banks, $pep, $mrna, $sbux, advanced micro devices, $intc, discord, $cat, $wmt, $ma, stocks energy, exxon mobil, $mtc, $hd, $ba, $jnj, $tgt, about to, $akesf, eli lilly, $hbt, walt disney, coins solana ecosystem, $wfc, $gm, warner bros discovery inc, costco, procter gamble, goldman sachs, $amzn, $pypl, block inc, microsoft, iii, momentum, $exel, $lly, $insm, click the, investment, $onc, $bmy, $orcl, $bac, $ibm, $gs, $amd, $sq, morgan stanley, manat, $cmnd, coins defi, $msft, market cap, $til, $eose, $ge, miller, spikes, $googl, jpmorgan chase, $cost, protocol, mcdonalds corp, $xom, jacob, $mdgl, united therapeutics corp

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$SMMT (-8.7% pre) Summit Therapeutics Shares Dip After Q3 Results Ivonescimab Strategy Moves Forward - msn"
X Link @OpenOutcrier 2025-10-20T12:31Z 80.1K followers, 2121 engagements

"Summit Therapeutics Inc. ($SMMT): SMMT Announces Positive Phase III Data Plans FDA Approval Filing"
Reddit Link @Educational_Cup9809 2025-10-20T12:18Z X followers, X engagements

"$SMMT plans to submit an application for approval of Ivonescimab to the FDA in Q4 - a very opportunistic approach in my opinion. Shares down X% pre-market. $MRK flat"
X Link @doepke_michel 2025-10-20T11:31Z 5636 followers, 1357 engagements

"Summit Therapeutics $SMMT Q3-25. Results: πŸ“Š Adj. EPS: -$0.13 πŸ”΄ πŸ’° Revenue: $X πŸ”΄ πŸ“ˆ Net Loss: $231.8M πŸ”Ž Summit plans BLA submission for ivonescimab in Q4 2025 following strong Phase III HARMONi trial results"
X Link @Earnings_Time 2025-10-20T11:22Z 12.3K followers, 1426 engagements

Summit Therapeutics Inc. Common Stock (SMMT)
/topic/$smmt